DCM
ABT icon

Defilade Capital Management’s Abbott ABT Stock Holding History

Defilade Capital Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9M Buy
+285,778
New +$26.1M 3.47% 11

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Defilade Capital Management's ABT Position: Q2 2026 in Review

Defilade Capital Management opened a new position in Abbott (ABT) in Q2 2026: 285,778 shares worth $25.9M. The stake represents 3.47% of the portfolio and ranks #11 among its holdings.

2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Defilade Capital Management held 285,778 shares of Abbott worth $25.9M as of Q2 2026.
  • Abbott was a new Defilade Capital Management position in Q2 2026.
  • Abbott made up 3.47% of Defilade Capital Management's portfolio in Q2 2026, its #11 holding.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Defilade Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.